QIAGEN N.V.: QIAGEN Confirms Effectiveness of Its SARS-CoV-2 PCR Tests in the Face of Mutations of the Coronavirus
QIAGEN N.V.: QIAGEN Confirms Effectiveness of Its SARS-CoV-2 PCR Tests in the Face of Mutations of the Coronavirus QIAGEN started cross-checking variants in May 2020 and continues to conduct biweekly assessments QIAseq SARS-CoV-2 Primer Panel helps with sequencing RNA and identifying mutations QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced its polymerase chain reaction (PCR) tests remain accurate and effective in detecting SARS-CoV-2 infections and will continue to closely monitor their performance as global concerns mount regarding the detection of new viral varian...
Source: finanznachrichten.de